XML 26 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Stock Subscription Receivable
Additional Paid-in Capital
Accumulated Deficit
Comprehensive Income
Treasury Stock
Noncontrolling Interest
Total
Balance at Dec. 31, 2017 $ 11,875 $ 14,874,924 $ (6,634,067) $ 743,763 $ (9,100,000) $ 806,761 $ 703,256
Balance, Shares at Dec. 31, 2017 11,874,814         (275,347)    
Issuance of common shares $ 10 79,990 80,000
Issuance of common shares, Shares 9,990              
Stock based compensation 5,626 5,626
Net loss for the year (601,387) (112,235) (713,622)
Cumulative transaction adjustments 64,994 64,994
Balance at Mar. 31, 2018 $ 11,885 14,960,540 (7,235,454) 808,757 $ (9,100,000) 694,526 140,254
Balance, Shares at Mar. 31, 2018 11,884,804         (275,347)    
Stock based compensation 10,200 10,200
Net loss for the year (632,170) (103,870) (736,040)
Cumulative transaction adjustments (134,054) (134,054)
Balance at Jun. 30, 2018 $ 11,885 14,970,740 (7,867,624) 674,703 $ (9,100,000) 590,656 (719,640)
Balance, Shares at Jun. 30, 2018 11,884,804         (275,347)    
Stock based compensation 7,577         7,577
Net loss for the year (570,809)     (116,491) (687,300)
Cumulative transaction adjustments   (12,040)     (12,040)
Balance at Sep. 30, 2018 $ 11,885 14,978,317 (8,438,433) 662,663 $ (9,100,000) 474,165 (1,411,403)
Balance, Shares at Sep. 30, 2018 11,884,804         (275,347)    
Balance at Dec. 31, 2018 $ 11,885 14,983,714 (12,209,446) 655,851 $ (9,100,000) 317,610 (5,340,386)
Balance, Shares at Dec. 31, 2018 11,884,804         (275,347)    
Issuance of common shares to BioKey $ 1,642 692,577 694,219
Issuance of common shares to BioKey, Shares 1,642,291              
Issuance of common shares to BioLite $ 4,167 (4,167)
Issuance of common shares to BioLite, Shares 4,166,530              
Issuance common stock for consulting service
Stock based compensation 8,550 8,550
Net loss for the year (791,671) (81,646) (873,317)
Cumulative transaction adjustments (15,412) (15,412)
Balance at Mar. 31, 2019 $ 17,694 15,680,674 (13,001,117) 640,439 $ (9,100,000) 235,964 (5,526,346)
Balance, Shares at Mar. 31, 2019 17,693,625         (275,347)    
Balance at Dec. 31, 2018 $ 11,885 14,983,714 (12,209,446) 655,851 $ (9,100,000) 317,610 (5,340,386)
Balance, Shares at Dec. 31, 2018 11,884,804         (275,347)    
Balance at Sep. 30, 2019 $ 19,478 (4,289,060) 28,180,123 (14,773,552) 628,941 $ (9,100,000) 64,261 730,191
Balance, Shares at Sep. 30, 2019 19,477,504         (275,347)    
Balance at Mar. 31, 2019 $ 17,694 15,680,674 (13,001,117) 640,439 $ (9,100,000) 235,964 (5,526,346)
Balance, Shares at Mar. 31, 2019 17,693,625         (275,347)    
Issuance of common shares $ 429 2,999,571 3,000,000
Issuance of common shares, Shares 428,571              
Stock based compensation 7,800 7,800
Net loss for the year (557,577) (56,877) (614,453)
Cumulative transaction adjustments (8,429) (8,429)
Balance at Jun. 30, 2019 $ 18,123 18,688,045 (13,558,694) 632,010 $ (9,100,000) 179,087 (3,141,428)
Balance, Shares at Jun. 30, 2019 18,122,196         (275,347)    
Issuance of common shares $ 1,355 (4,289,060) 9,486,339 5,198,634
Issuance of common shares, Shares 1,355,308              
Stock based compensation 5,739 5,739
Net loss for the year (1,214,859) (114,826) (1,329,685)
Cumulative transaction adjustments (3,069) (3,069)
Balance at Sep. 30, 2019 $ 19,478 $ (4,289,060) $ 28,180,123 $ (14,773,552) $ 628,941 $ (9,100,000) $ 64,261 $ 730,191
Balance, Shares at Sep. 30, 2019 19,477,504         (275,347)